What does an Expanded Access Program mean for GIST patients?
Pharmaceutical companies may create an Expanded Access Program (sometimes called compassionate use) when a clinical trial is no longer enrolling but the medicine still shows promise.
Clinical Trials & Nutrition
Nutrition is important to keep in mind during any cancer treatment, but especially during a clinical trial.
Clinical Trials Wednesday – Kandee Evans Shares
GISTer Kandee Evans openly shares her experiences as a new clinical trial participant in the StrateGIST 1 trial sponsored by IDRx.
Clinical Trial for Ripretinib
Studies have shown that if you have GIST with mutations in KIT exons 11 and 17/18, ripretinib may be a better option for second-line treatment than the standard sunitinib.
The Impact of Clinical Trials on Treatment Options
Clinical trials are an essential part of medical research, aimed at introducing new procedures and treatments to the public.
What are Clinical Trials & How Do You Find Them?
Clinical trials are scientific research studies done in humans that help us to understand whether a new treatment is safe and effective in treating an illness, such as cancer.
New Clinical Trials Focus for the LRG in 2024
Starting in January, every Wednesday will be dedicated learning about clinical trial process and to highlighting the groundbreaking clinical trials focused on gastrointestinal stromal tumors (GIST).
Summary of Phase 3 INTRIGUE Trial Published
This summary article helps explain the results of Deciphera's Phase 3 INTRIGUE trial as published in Future Medicine, authored by Marina Symcox & Robin L Jones.
Theseus Ends THE-630 Trial
Theseus Pharmaceuticals announced yesterday the discontinuation of enrollment in the Phase 1/2 study and terminating the development of THE-630 for GIST patients with advanced or metastatic GIST. The company reported dose-limiting toxicities relating to [...]
Progress in Precision Medicine for GIST Patients
These new data were presented by Dr. Sebastian Bauer and Dr. Breelyn A. Wilky during the 2023 January ASCO Plenary Series from the INTRIGUE Efficacy Results of ctDNA Analysis for GIST Patients.